Irsko - angličtina - HPRA (Health Products Regulatory Authority)

hospira uk limited - remifentanil hydrochloride - pdr/conc/soln/inj/inf - 2 milligram - opioid anesthetics

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

hospira uk limited - remifentanil hydrochloride - pdr/conc/soln/inj/inf - 5 milligram - opioid anesthetics

Spojené státy - angličtina - NLM (National Library of Medicine)

mylan institutional llc - remifentanil hydrochloride (unii: 5v444h5wic) (remifentanil - unii:p10582jyyk) - remifentanil 1 mg in 1 ml - ultiva is indicated for intravenous (iv) administration: ultiva is contraindicated: prolonged use of opioid analgesics during pregnancy may cause neonatal opioid withdrawal syndrome. available data with remifentanil hydrochloride in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage. in animal reproduction studies, reduced fetal rat body weight and pup weights were reported at 2.2 times a human intravenous infusion of an induction dose of 1 mcg/kg with a maintenance dose of 2 mcg/kg/min for a surgical procedure lasting 3 hours. there were no malformations noted when remifentanil was administered via bolus injection to pregnant rats or rabbits during organogenesis at doses approximately 5 times and approximately equal, respectively, to a human intravenous infusion of an induction dose of 1 mcg/kg with a maintenance dose of 2 mcg/kg/min for a surgical procedure lasting 3 hours [see data ]. the estimated background risk of major birth defects and miscarriage

Panama - angličtina - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

hameln pharma gmbh - remifentanilo (clorhidrato) - remifentanilo (clorhidrato)....5 mg

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

remifentanil hydrochloride -

Panama - angličtina - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios richet, s.a. - remifentanilo (clorhidrato) - remifentanilo (clorhidrato)....5.00 mg

Izrael - angličtina - Ministry of Health

padagis israel agencies ltd, israel - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 5 mg/vial - remifentanil - remifentanil - ultiva is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision . ultiva is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - remifentanil hydrochloride -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - remifentanil hydrochloride -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - remifentanil hydrochloride -